LabHealth
CDK2 inhibitor plus immunotherapy erased tumors in animal models
Combined with an immune checkpoint inhibitor, tegtociclib erased colorectal and breast tumors in animal models.
Written by AI1 source2 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
Combined with an immune checkpoint inhibitor, tegtociclib erased colorectal and breast tumors in animal models.
The model also showed less aggressive cells becoming mobile after they detached from neighboring cells and entered small tissue spaces.
The four-day treatment used organoids grown from mouse tumors and patient samples.
The MUSC team weakened resistant cancer cells before blocking their backup survival pathway.
The study focuses on mucinous colorectal adenocarcinoma, an aggressive cancer accounting for around 10%–15% of cases.
Researchers at National Taiwan University built the first spatial map of ovarian clear cell carcinoma.
Peter Mac researchers identified four proteins pancreatic cancer cells rely on to grow and survive.
The molecule, TR-07, selectively activates PRMT1 instead of blocking it.
IOCAS researchers linked an oyster energy-stress pathway to glycolysis in human lung adenocarcinoma cells.
Risca's team tracked liposarcoma and ER-positive breast cancer cells for nearly a month.
The molecules reduced lung, breast cancer and melanoma cell viability in laboratory tests.